Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival
This multi-centric study from Europe, North America and Australasia looked at more than 6000 women who had been diagnosed with ovarian cancer. The use of hormone replacement therapy prior to diagnosis and the survival were measured.
The type of hormone therapy; whether oestrogen only or combined oestrogen/progesterone was recorded. The duration of the hormone replacement was also available.
The results show that taking both oestrogen only or combined therapy, for 5 years or more before diagnosis, improved survival by 20%.
No comments:
Post a Comment